(5'-bromo-2'-oxo-2',3'-dihydrospiro[1,3-dioxolane-2,3'-(1'H)-indol]-1'-yl)acetic acid | 331267-94-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (5'-bromo-2'-oxo-2',3'-dihydrospiro[1,3-dioxolane-2,3'-(1'H)-indol]-1'-yl)acetic acid
• 英文别名: 2-(5'-bromo-2'-oxospiro[1,3-dioxolane-2,3'-indole]-1'-yl)acetic acid
• CAS: 331267-94-8
• 化学式: C₁₂H₁₀BrNO₅
• 分子量: 328.119
• InChiKey: GDDRRTQDCBOYAK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  76.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (5'-bromo-2'-oxo-2',3'-dihydrospiro[1,3-dioxolane-2,3'-(1'H)-indol]-1'-yl)acetic acid 在 N-甲基吗啉 、 羟胺钾盐 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 15.0h， 生成 2-(5'-bromo-2'-oxospiro[[1,3]dioxolane-2,3'-indoline]-1'-yl)-N-(2-(hydroxyamino)-2-oxoethyl)acetamide
  参考文献：
  名称：

  Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN)

  摘要：

  Aminopeptidase N (APN/CD13), as a zinc-containing ectoenzyme, plays a critical role in the process of tumor angiogenesis, invasion and metastasis. Through the docking-based virtual screening of chemical databases and the further activity assay, we discovered that compound 10c exhibits potent and selective inhibitory ability towards APN. In addition, a series of indoline-2,3-dione derivates have been designed and synthesized as APN inhibitors. The results of preliminary activity evaluation showed that compound 12a (IC50 = 0.074 +/- 0.0026 mu M) exhibited the best inhibitory activity against APN, which could be used for further anticancer agent research. (C) 2012 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2012.06.024
• 作为产物：
  描述：

  N-(4-bromophenyl)-2-(hydroxyimino) acetamide 在 硫酸 、 四丁基溴化铵 、 potassium carbonate 、 对甲苯磺酸 、 potassium iodide 、 potassium hydroxide 作用下， 以 乙醇 、 水 、 丙酮 、 甲苯 为溶剂， 反应 11.5h， 生成 (5'-bromo-2'-oxo-2',3'-dihydrospiro[1,3-dioxolane-2,3'-(1'H)-indol]-1'-yl)acetic acid
  参考文献：
  名称：

  Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN)

  摘要：

  Aminopeptidase N (APN/CD13), as a zinc-containing ectoenzyme, plays a critical role in the process of tumor angiogenesis, invasion and metastasis. Through the docking-based virtual screening of chemical databases and the further activity assay, we discovered that compound 10c exhibits potent and selective inhibitory ability towards APN. In addition, a series of indoline-2,3-dione derivates have been designed and synthesized as APN inhibitors. The results of preliminary activity evaluation showed that compound 12a (IC50 = 0.074 +/- 0.0026 mu M) exhibited the best inhibitory activity against APN, which could be used for further anticancer agent research. (C) 2012 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2012.06.024

文献信息

• Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o -phenylenediamine-based zinc binding groups
  作者：Shuai Gao、Jie Zang、Qianwen Gao、Xuewu Liang、Qinge Ding、Xiaoyang Li、Wenfang Xu、C. James Chou、Yingjie Zhang

  DOI：10.1016/j.bmc.2017.03.036

  日期：2017.6

  As a hot topic of epigenetic studies, histone deacetylases (HDACs) are related to lots of diseases, especially cancer. Further researches indicated that different HDAC isoforms played various roles in a wide range of tumor types. Herein a novel series of HDAC inhibitors with isatin-based caps and o-phenylenediamine-based zinc binding groups have been designed and synthesized through scaffold hopping

  作为表观遗传学研究的热门话题，组蛋白脱乙酰基酶（HDAC）与许多疾病，尤其是癌症有关。进一步的研究表明，不同的HDAC亚型在多种肿瘤类型中起着不同的作用。在本文中，已经设计并通过支架跳跃策略合成了一系列具有基于靛红的帽和基于邻苯二胺的锌结合基团的HDAC抑制剂。在这些化合物中，与阳性对照恩替司他（MS-275）相比，最有效的化合物9n对多种肿瘤细胞系表现出相似的，甚至不是更好的HDAC抑制作用和抗增殖活性。此外，与MS-275（HDAC1、2和3的IC50值分别为0.163、0.396和0.605µM）相比，化合物9n的HDAC1、2和3的IC50值分别为0.032、0.256和0.311µM，
• Design, synthesis and preliminary biological evaluation of indoline-2,3-dione derivatives as novel HDAC inhibitors
  作者：Kang Jin、Shanshan Li、Xiaoguang Li、Jian Zhang、Wenfang Xu、Xuechen Li

  DOI：10.1016/j.bmc.2015.05.048

  日期：2015.8

  Histone deacetylases (HDACs) are zinc-dependent or NAD+ dependent enzymes and play a critical role in the process of tumor development. Herein a series of indoline-2,3-dione derivatives have been designed and synthesized as potential HDACs inhibitors. The preliminary biological evaluation showed that most compounds synthesized have exhibited moderate Hela cell nuclear extract inhibitory activities, among which compound 25a (IC50 = 10.13 nM) has shown the best efficacy. The anti-proliferative activities of some of these compounds were also discussed. (C) 2015 Published by Elsevier Ltd.